COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
Top Cited Papers
Open Access
- 30 March 2020
- journal article
- research article
- Published by Ecancer Global Foundation in ecancermedicalscience
- Vol. 14, 1023
- https://doi.org/10.3332/ecancer.2020.1023
Abstract
Given the current SARS-CoV-2 (COVID-19) pandemic, the availability of reliable information for clinicians and patients is paramount. There have been a number of reports stating that non-steroidal anti-inflammatory drugs (NSAIDs) and corticosteroids may exacerbate symptoms in COVID-19 patients. Therefore, this review aimed to collate information available in published articles to identify any evidence behind these claims with the aim of advising clinicians on how best to treat patients. This review found no published evidence for or against the use of NSAIDs in COVID-19 patients. Meanwhile, there appeared to be some evidence that corticosteroids may be beneficial if utilised in the early acute phase of infection, however, conflicting evidence from the World Health Organisation surrounding corticosteroid use in certain viral infections means this evidence is not conclusive. Given the current availability of literature, caution should be exercised until further evidence emerges surrounding the use of NSAIDs and corticosteroids in COVID-19 patients.Keywords
This publication has 14 references indexed in Scilit:
- Decoding the enigma of antiviral crisis: Does one target molecule regulate all?Cytokine, 2019
- The management of coronavirus infections with particular reference to SARSJournal of Antimicrobial Chemotherapy, 2008
- Cytokine Responses in Porcine Respiratory Coronavirus-Infected Pigs Treated with Corticosteroids as a Model for Severe Acute Respiratory SyndromeJournal of Virology, 2008
- Indomethacin Has a Potent Antiviral Activity against Sars CoronavirusAntiviral Therapy, 2006
- [A study of pulmonary inflammatory reaction induced by N-protein of SARS-CoV in rat models and effects of glucocorticoids on it].2005
- Overview of antiviral and anti-inflammatory treatment for severe acute respiratory syndromeExpert Review of Anti-infective Therapy, 2005
- High-dose hydrocortisone reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10 in SARS coronavirus-infected intestinal cellsInternational Journal of Molecular Medicine, 2005
- Severe acute respiratory syndrome: clinical and laboratory manifestations.2004
- Plasma inflammatory cytokines and chemokines in severe acute respiratory syndromeClinical and Experimental Immunology, 2004
- Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR ChinaJournal of Medical Microbiology, 2003